Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients

Archive ouverte

Magnotti, Flora | Lefeuvre, Lucie | Benezech, Sarah | Malsot, Tiphaine | Waeckel, Louis | Martin, Amandine | Kerever, Sebastien | Chirita, Daria | Desjonqueres, Marine | Duquesne, Agnès | Gerfaud-Valentin, Mathieu | Laurent, Audrey | Sève, Pascal | Popoff, Michel-Robert | Walzer, Thierry | Belot, Alexandre | Jamilloux, Yvan | Henry, Thomas

Edité par CCSD ; Wiley Open Access -

International audience. Familial Mediterranean fever (FMF) is the most frequent hereditary systemic autoinflammatory syndrome. FMF is usually caused by biallelic mutations in the MEFV gene, encoding Pyrin. Conclusive genetic evidence lacks for about 30% of patients diagnosed with clinical FMF. Pyrin is an inflammasome sensor maintained inactive by two kinases (PKN1/2). The consequences of MEFV mutations on inflammasome activation are still poorly understood. Here, we demonstrate that PKC superfamily inhibitors trigger inflammasome activation in monocytes from FMF patients while they trigger a delayed apoptosis in monocytes from healthy donors. The expression of the pathogenic p.M694V MEFV allele is necessary and sufficient for PKC inhibitors (or mutations precluding Pyrin phosphorylation) to trigger caspase-1- and gasdermin D-mediated pyroptosis. In line with colchicine efficacy in patients, colchicine fully blocks this response in FMF patients' monocytes. These results indicate that Pyrin inflammasome activation is solely controlled by Pyrin (de)phosphorylation in FMF patients while a second control mechanism restricts its activation in healthy donors/non-FMF patients. This study paves the way toward a functional characterization of MEFV variants and a functional test to diagnose FMF.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion